Home Compare BIM.PA vs HCA
Stock Comparison · Comparison

bioMérieux vs HCA Healthcare: Which Stock Looks Stronger in 2026?

HCA Healthcare holds the cleaner structural position, with the lead spread across growth and valuation. bioMérieux still has the edge on stability, which keeps the comparison from looking entirely one-sided. On the market side, HCA Healthcare is in better shape — its trend is intact while bioMérieux's trend has broken down. That puts structure and market broadly in agreement — HCA Healthcare's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in growth, but valuation adds another real layer to the result. The overall score gap is 24 points in favour of HCA Healthcare, Inc..

Trajectory Similarity
0.78
Similar
Peer-set rank: #4
within bioMérieux S.A.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

The strongest overlap appears in margin consistency and revenue stability.

Similarity drivers
margin consistencyrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BIM.PA
bioMérieux S.A.
46
Peer-Score
Signal qualityHigh
vs
HCA
HCA Healthcare, Inc.
70
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: BIM.PA vs HCA Profitability 49 72 Stability 72 58 Valuation 46 84 Growth 17 59 BIM.PA HCA
Gap Ranking
#1 Growth +42
#2 Valuation +38
#3 Profitability +23
#4 Stability +14
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BIM.PA and HCA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BIM.PAHCA Relative valuation Structural strength

HCA Healthcare, Inc. looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, HCA Healthcare, Inc. is positioned higher in the group, while bioMérieux S.A. is closer to the middle.
Valuation
Both profiles are strong on valuation, but HCA Healthcare, Inc. leads clearly.
Growth — Dominant Gap
BIM.PA
17
HCA
59
Gap+42in favour of HCA

One company is still expanding while the other is contracting, which creates a very wide growth split.

What keeps the gap from being one-sided

bioMérieux S.A. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both growth and valuation — though stability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the BIM.PA vs HCA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-valuation comparisons

Explore how BIM.PA and HCA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.